Covid-19 roundup: Fauci says multibillion-dollar program could curb future pandemics; Japanese drugmaker spices up coronavirus pill race

Josh Sullivan

When the Covid-19 pandemic swept in, drugmakers were able to spin years worth of research into the fastest turnaround time for vaccine development the world …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Fauci says multibillion-dollar program could curb future pandemics; Japanese drugmaker spices up coronavirus pill race

Josh Sullivan

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint

Shoreline cuts staff as its partnership with Gilead's Kite is now in flux

Versant unveils Light Horse with $62M and a partnership with Novartis

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Cell therapy startup A2 Biotherapeutics nets $80M Series C

Covid-19 roundup: Fau­ci says multi­bil­lion-dol­lar pro­gram could curb fu­ture pan­demics; Japan­ese drug­mak­er spices up coro­n­avirus pill race

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Covid-19 roundup: Fauci says multibillion-dollar program could curb future pandemics; Japanese drugmaker spices up coronavirus pill race